Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina

Am J Trop Med Hyg. 2004 Aug;71(2):153-9.

Abstract

Infections with hepatitis C virus, (HCV), hepatitis B virus (HBV), and human T lymphotropic type I/II (HTLV-I/II) virus are commonly found in patients infected with human immunodeficiency virus type 1 (HIV-1). We conducted a seroepidemiologic study among 174 HIV-positive heterosexuals in Buenos Aires, Argentina in 1999. Evidence of exposure to HCV, HBV, and HTLV-I/II was found in 32%, 17%, and 5%, respectively. A higher prevalence of HBV infection was observed among males (33%) compared with females (12%; P < 0.05). Among women, a prior history of a sexually transmitted infection, injecting drug use (IDU), having had more than five lifetime sex partners, and having exchanged sex-for-goods were significantly associated with HCV infection, whereas an IDU history, syringe sharing, and having exchanged sex-for-goods were found to be associated with HBV infection. Among men, an IDU history and syringe/needle sharing were significantly associated with HCV infection. The IDU-related and sexual transmission of hepatitis viruses constitute a significant problem among young, HIV-infected, heterosexuals in Argentina.

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Argentina / epidemiology
  • Cross-Sectional Studies
  • Female
  • HIV Infections / complications*
  • HIV Infections / epidemiology*
  • HIV-1 / immunology
  • HTLV-I Infections / complications
  • HTLV-I Infections / epidemiology*
  • HTLV-II Infections / complications
  • HTLV-II Infections / epidemiology*
  • Hepacivirus / immunology
  • Hepatitis B / complications
  • Hepatitis B / epidemiology*
  • Hepatitis B virus / immunology
  • Hepatitis C / complications
  • Hepatitis C / epidemiology*
  • Heterosexuality*
  • Human T-lymphotropic virus 1 / immunology
  • Human T-lymphotropic virus 2 / immunology
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral